J Alexander Viehman1, Cornelius J Clancy, Lloyd Clarke, Ryan K Shields, Fernanda P Silveira, Eun J Kwak, Pascalis Vergidis, Christopher Hughes, Abhinav Humar, M Hong Nguyen. 1. 1 Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA. 2 Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA. 3 Infectious Diseases Section, VA Pittsburgh Healthcare System, Pittsburgh, PA. 4 Antibiotic Management Program, University of Pittsburgh Medical Center, Pittsburgh, PA. 5 Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, PA. 6 Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA. 7 Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Abstract
BACKGROUND: Perioperative antimicrobial prophylaxis is administered to liver transplant (LTx) recipients to prevent surgical site infections (SSIs), but regimens are not standardized, and there are limited effectiveness data. Prevention and treatment of SSIs have been complicated by the emergence of multidrug-resistant (MDR) pathogens. METHODS: We retrospectively reviewed SSIs among 331 LTx recipients at our center in 2010 to 2014. RESULTS: Culture-proven superficial and deep SSIs occurred in 3% and 15% of patients, respectively, at median 12.5 and 13.5 days post-LTx. Recipients with superficial SSIs and those without SSIs were similar in demographics, clinical characteristics, length of hospital stay, and mortality. Deep SSIs included abscesses (58%), peritonitis (28%), deep incisional infections (8%), and cholangitis (6%). Rates of deep SSIs were comparable among patients receiving prophylaxis with ampicillin-sulbactam, aztreonam and vancomycin, or tigecycline (P = 0.61). Independent risk factors for deep SSIs were bile leak (P < 0.001) and operative time (P < 0.001). Enterobacteriaceae (42%), Enterococcus spp. (24%), and Candida spp. (15%) were predominant pathogens. Fifty-three percent of bacteria were MDR, including 95% of Enterococcus faecium and 55% of Enterobacteriaceae; 82% of deep SSIs were caused by bacteria resistant to antimicrobials used for prophylaxis, and 58% of patients were treated with an inactive empiric regimen. Deep SSIs were associated with longer lengths of stay (P < 0.001), and higher 90-day and long-term mortality rates (P < 0.001). CONCLUSIONS: Deep SSIs, including those caused by MDR bacteria, were common after LTx despite prophylaxis with broad-spectrum antimicrobials. Rather than altering prophylaxis regimens, programs should devise empiric treatment regimens that are directed against the most common local pathogens.
BACKGROUND: Perioperative antimicrobial prophylaxis is administered to liver transplant (LTx) recipients to prevent surgical site infections (SSIs), but regimens are not standardized, and there are limited effectiveness data. Prevention and treatment of SSIs have been complicated by the emergence of multidrug-resistant (MDR) pathogens. METHODS: We retrospectively reviewed SSIs among 331 LTx recipients at our center in 2010 to 2014. RESULTS: Culture-proven superficial and deep SSIs occurred in 3% and 15% of patients, respectively, at median 12.5 and 13.5 days post-LTx. Recipients with superficial SSIs and those without SSIs were similar in demographics, clinical characteristics, length of hospital stay, and mortality. Deep SSIs included abscesses (58%), peritonitis (28%), deep incisional infections (8%), and cholangitis (6%). Rates of deep SSIs were comparable among patients receiving prophylaxis with ampicillin-sulbactam, aztreonam and vancomycin, or tigecycline (P = 0.61). Independent risk factors for deep SSIs were bile leak (P < 0.001) and operative time (P < 0.001). Enterobacteriaceae (42%), Enterococcus spp. (24%), and Candida spp. (15%) were predominant pathogens. Fifty-three percent of bacteria were MDR, including 95% of Enterococcus faecium and 55% of Enterobacteriaceae; 82% of deep SSIs were caused by bacteria resistant to antimicrobials used for prophylaxis, and 58% of patients were treated with an inactive empiric regimen. Deep SSIs were associated with longer lengths of stay (P < 0.001), and higher 90-day and long-term mortality rates (P < 0.001). CONCLUSIONS: Deep SSIs, including those caused by MDR bacteria, were common after LTx despite prophylaxis with broad-spectrum antimicrobials. Rather than altering prophylaxis regimens, programs should devise empiric treatment regimens that are directed against the most common local pathogens.
Authors: Amy G Feldman; Brenda L Beaty; Donna Curtis; Elizabeth Juarez-Colunga; Allison Kempe Journal: JAMA Pediatr Date: 2019-03-01 Impact factor: 16.193
Authors: Wojciech Figiel; Michał Grąt; Grzegorz Niewiński; Waldemar Patkowski; Krzysztof Zieniewicz Journal: Sci Rep Date: 2020-03-03 Impact factor: 4.379
Authors: Diego Foschi; Al'ona Yakushkina; Francesco Cammarata; Giulia Lamperti; Francesco Colombo; Sara Rimoldi; Spinello Antinori; Gianluca M Sampietro Journal: Updates Surg Date: 2022-03-19
Authors: Khalid Mumtaz; Jannel Lee-Allen; Kyle Porter; Sean Kelly; James Hanje; Lanla F Conteh; Anthony J Michaels; Ashraf El-Hinnawi; Ken Washburn; Sylvester M Black; Marwan S Abougergi Journal: Sci Rep Date: 2020-11-06 Impact factor: 4.379
Authors: Nora Chea; Mathew R P Sapiano; Liang Zhou; Lauren Epstein; Alice Guh; Jonathan R Edwards; Katherine Allen-Bridson; Victoria Russo; Jennifer Watkins; Stephanie M Pouch; Shelley S Magill Journal: Transpl Infect Dis Date: 2021-03-23